Loading clinical trials...
Loading clinical trials...
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nantes University Hospital
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06553053 · Crohn's Disease Relapse, Inflammatory Bowel Diseases
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT05986136 · Inflammatory Bowel Diseases
NCT06266663 · Inflammatory Bowel Diseases
CHU de Nantes
Nantes
Clinique Jules Verne
Nantes
Hopital Privé du Confluent
Nantes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions